Psoriasis

Medical Clinics of North America

Volumn 82, Issue 5, 1998, Pages 1135-1144

  Feldman, S R ^a   Clark, A R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL; CORTICOSTEROID; DITHRANOL; FLUOCINONIDE; HYDROCORTISONE; KETOCONAZOLE; LITHIUM; METHOTREXATE; MOMETASONE FUROATE; PYRITHIONE ZINC; TAR; TAZAROTENE; UNCLASSIFIED DRUG; VITAMIN D; VYTONE;

DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN TISSUE; HUMIDIFIER; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; REVIEW; RISK FACTOR;

EID: 0031710768     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70406-5     Document Type: Article

References (33)

1. M.J. Boffa R.J. Chalmers N.Y. Haboubi Sequential liver biopsies during long-term methotrexate treatment for psoriasis: A reappraisal Br J Dermatol 133 1995 774 778
2. S. Bruce W.W. Epinette T. Funicella Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis J Am Acad Dermatol 31 1994 755 759
3. C. Camisa Psoriasis 1994 Blackwell Scientific Publications Oxford
4. C. Camisa Treatment of severe psoriasis with systemic drugs Dermatol Nurs 7 1995 107 118
5. S.I. Cullen Long-term effectiveness and safety of topical calcipotriene for psoriasis. Calcipotriene Study Group South Med J 89 1996 1053 1056
6. De Jong E.M. B.A. Seegers M.K. Gulinck Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1,728 patients Dermatology 193 1996 300 303
7. P.M. Farr L.B. Krause J.M. Marks Response of scalp psoriasis to oral ketoconazole Lancet 2 1985 921 922
8. S.R. Feldman Psoriasis treatment Curr Probl Dermatol 10 1998 1 40
9. Fleischer A.B. Jr S.R. Feldman D.D. Bradham Office-based physician services provided by dermatologists in the United States in 1990 J Invest Dermatol 102 1994 93 97
10. Fleischer A.B. Jr S.R. Feldman S.R. Rapp Disease severity measures in a population of psoriasis patients: The symptoms of psoriasis correlate with self-administered psoriasis area severity index scores J Invest Dermatol 107 1996 26 29
11. Fleischer A.B. Jr S.R. Feldman S.R. Rapp Alternative therapies commonly used within a population of patients with psoriasis Cutis 58 1996 216 220
12. C. Green M. Ganpule D. Harris Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalp Br J Dermatol 130 1994 483 487
13. C. Guzzo G. Lazarus B.S. Goffe Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis J Am Acad Dermatol 34 1996 429 433
14. T.N. Helm C. Camisa Psoriasis of the scalp Camisa C. Psoriasis 1994 Blackwell Scientific Cambridge, MA 85 96
15. Jeffes E.W. III G.D. Weinstein Methotrexate and other chemotherapeutic agents used to treat psoriasis Dermatol Clin 13 1995 875 890
16. S. Kienbaum P. Lehmann T. Ruzicka Topical calcipotriol in the treatment of intertriginous psoriasis Br J Dermatol 135 1996 647 650
17. M.R. Klaber P.E. Hutchinson A. Pedvis-Leftick Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis Br J Dermatol 131 1994 678 683
18. B. Kumar S. Handa I. Kaur Short term methotrexate therapy in psoriasis Ind J Med Res 100 1994 277 280
19. C.M. Lawrence J. Marks S. Parker A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis Br J Dermatol 110 1984 221 226
20. M. Lebwohl S.B. Siskin W. Epinette A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis J Am Acad Dermatol 35 1996 268 269
21. A.R. Marsico W.H. Eaglstein G.D. Weinstein Ultraviolet light and tar in the Goeckerman treatment of psoriasis Arch Dermatol 112 1976 1249 1250
22. W.L. Morison PUVA therapy Weinstein G.D. Gottlieb A.B. Therapy of Moderate-to-Severe Psoriasis 1993 National Psoriasis Foundation Portland, OR 23 38
23. E.A. Olsen D.L. Cram C.N. Ellis A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis J Am Acad Dermatol 24 1991 443 447
24. D.M. Pariser R.J. Pariser D. Breneman Calcipotriene ointment applied once a day for psoriasis: A double-blind, multicenter, placebo-controlled study [letter] Arch Dermatol 132 1996 1527
25. S.R. Rapp M.L. Exum D.M. Reboussin The physical, psychological and social impact of psoriasis J Health Psychol 2 1997 525 537
26. Roenigk H.H. Jr R. Auerbach H.I. Maibach Methotrexate in psoriasis: Revised guidelines J Am Acad Dermatol 19 1988 145 156
27. R.S. Stern K.T. Nichols L.H. Vakeva Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA) N Engl J Med 336 1997 1041 1045
28. R.S. Stern L.H. Vakeva Noncutaneous malignant tumors in the PUVA follow-up study: 1975–1996 J Invest Dermatol 108 1997 897 900
29. G. Volden A. Bjornberg E. Tegner Short-contact treatment at home with Micanol Acta Derm Venereol 172 supplementum 1992 20 22
30. J.C. Wang R.J. Krazmien C.E. Dahlheim Anthralin stain removal J Am Acad Dermatol 15 1986 951 955
31. G.D. Weinstein J.G. Krueger An overview of psoriasis Weinstein G.D. Gottlieb A.B. Therapy of Moderate-to-Severe Psoriasis 1993 National Psoriasis Foundation Portland, OR 1 22
32. G.D. Weinstein G.G. Krueger N.J. Lowe Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect J Am Acad Dermatol 37 1997 85 92
33. M.D. Zanolli E.F. Sherertz A.E. Hedberg Methotrexate: Anti-inflammatory or antiproliferative? J Am Acad Dermatol 22 1997 523 524